The Balancing Act® Thinks Outside the Lunch Box with Celebrity Chef Ralph Pagano
July 6, 2016
FOR IMMEDIATE RELEASE
Maruchan takes center stage with their yakisoba noodles on Lifetime® Television.
(DEERFIELD BEACH, Fla. – PR LOG – July 6, 2016) The Balancing Act® welcomes experts on a Japanese noodle dish, Thursday, July 7 and Wednesday, July 13, 2016 at 7:30 a.m. (ET/PT) on Lifetime®.
Don’t miss this special guest on The Balancing Act:
Breaking Out of the Lunchtime Rut – with Maruchan
Yakisoba noodles are a Japanese dish that traditionally refers to pan fried noodles mixed with seasonings, vegetables and sliced meat. But that’s not all you can do with them! Celebrity Chef Ralph Pagano joins The Balancing Act to demonstrate how just how versatile these noodles are. Using Maruchan’s version, which cooks in just four minutes, he shows viewers how to make a Fried Yakisoba Noodle Sandwich! For more unexpected recipes, go to www.Maruchan.com and check out their full line of products.
About The Balancing Act®
Entering its 8th season, The Balancing Act continues to empower women in all aspects of their lives. The mission at The Balancing Act is simple – to help today’s modern woman balance it all by bringing them positive solutions to enrich and empower them. Entertaining, educational and trusted by women, viewers can tune in to America’s premier morning show The Balancing Act on weekday mornings Monday through Friday at 7:30 am (ET/PT) on Lifetime television. For additional information or to view a segment visit: www.thebalancingact.com.
Join the Conversation!
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.